SAN LEANDRO, Calif.--(BUSINESS WIRE)--Dec. 19, 2005--Elsevier MDL today announced an agreement with the National Institute of Health (NIH) to contribute to the NIH effort to catalog information on the biological properties of small molecules in its freely available PubChem database. Elsevier MDL will enrich the growing PubChem resource for the scientific community by furnishing chemical structures from Elsevier’s xPharm(R) database, giving scientists with an xPharm license the ability to move from biological data in PubChem to more focused pharmacology data in xPharm that is essential to drug research.
